Ponoi II Management, LLC, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 9,900 shares at $5.00 ($50K) on 2023-01-23, disclosed to the SEC on 2023-01-25.
Open-market purchase of $50k NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| CNST | SELL | 2021-02-19 | $370K | — | Filing → |
| RAPT | SELL | 2020-09-23 | $18.8M | — | Filing → |
| NGM | BUY | 2019-10-11 | $924K | — | Filing → |